ES2528321T3 - Detección de a-fucosilación en anticuerpos - Google Patents
Detección de a-fucosilación en anticuerpos Download PDFInfo
- Publication number
- ES2528321T3 ES2528321T3 ES10757221.6T ES10757221T ES2528321T3 ES 2528321 T3 ES2528321 T3 ES 2528321T3 ES 10757221 T ES10757221 T ES 10757221T ES 2528321 T3 ES2528321 T3 ES 2528321T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- fucosylation
- antibodies
- detection
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/40—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving amylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01096—Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/17—Metallocarboxypeptidases (3.4.17)
- C12Y304/17002—Carboxypeptidase B (3.4.17.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/968—Plasmin, i.e. fibrinolysin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
- G01N2440/38—Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Método para detectar la presencia o la ausencia de residuos de fucosa dentro de un anticuerpo glucosilado o de un fragmento del mismo, que comprende: a) eliminación enzimática de residuos sacáridos heterogéneos de la proteína, b) eliminación enzimática de otros residuos heterogéneos de la proteína, c) posterior análisis de la proteína, en el que la eliminación en la etapa a) se lleva a cabo con Endo S y Endo H.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09172130 | 2009-10-02 | ||
EP09172130 | 2009-10-02 | ||
PCT/EP2010/064291 WO2011039150A1 (en) | 2009-10-02 | 2010-09-28 | A-fucosylation detection in antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2528321T3 true ES2528321T3 (es) | 2015-02-06 |
Family
ID=43037129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10757221.6T Active ES2528321T3 (es) | 2009-10-02 | 2010-09-28 | Detección de a-fucosilación en anticuerpos |
Country Status (8)
Country | Link |
---|---|
US (3) | US20120196310A1 (es) |
EP (1) | EP2483693B1 (es) |
JP (2) | JP2013506404A (es) |
CN (1) | CN102511007B (es) |
CA (1) | CA2773882C (es) |
ES (1) | ES2528321T3 (es) |
HK (1) | HK1168653A1 (es) |
WO (1) | WO2011039150A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101591671B1 (ko) * | 2011-04-29 | 2016-02-04 | 바이오콘 리서치 리미티드 | 항체의 이질성을 감소시키는 방법 및 그 항체의 제조방법 |
GB201115841D0 (en) * | 2011-09-13 | 2011-10-26 | Genovis Ab | Protein and method |
EP2768845B1 (en) | 2011-10-19 | 2017-01-18 | Roche Glycart AG | Separation method for fucosylated antibodies |
WO2013120066A1 (en) | 2012-02-10 | 2013-08-15 | University Of Maryland, Baltimore | Chemoenzymatic glycoengineering of antibodies and fc fragments thereof |
TWI682033B (zh) * | 2014-03-17 | 2020-01-11 | 泉盛生物科技股份有限公司 | 製造具有經修飾的糖苷化作用之重組糖蛋白之方法 |
JP6750148B2 (ja) * | 2014-04-25 | 2020-09-02 | 公益財団法人野口研究所 | 糖鎖切断抗体の製造方法及び均一糖鎖抗体 |
EP3064507A1 (en) | 2015-03-06 | 2016-09-07 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced affinity for IL15ra and therapeutic uses thereof |
EP3414328B1 (en) | 2016-02-08 | 2024-01-10 | Synaffix B.V. | Enzymes for trimming of glycoproteins |
CN108982737B (zh) * | 2018-08-07 | 2021-06-22 | 中国人民解放军军事科学院军事医学研究院 | 一种规模化的核心岩藻糖基化修饰位点占有率定量方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126250A (en) * | 1988-09-28 | 1992-06-30 | Eli Lilly And Company | Method for the reduction of heterogeneity of monoclonal antibodies |
JP4253233B2 (ja) * | 2003-08-25 | 2009-04-08 | 大塚製薬株式会社 | 術後癌患者の予後判定方法 |
US8207303B2 (en) * | 2005-02-18 | 2012-06-26 | Medarex, Inc. | Monoclonal antibodies against CD30 lacking in fucosyl residues |
CN101238148A (zh) * | 2005-06-03 | 2008-08-06 | 健泰科生物技术公司 | 具有改良的岩藻糖化水平的抗体的生产方法 |
US20070166306A1 (en) * | 2006-01-17 | 2007-07-19 | Fey Georg H M | Anti-CD19 antibody composition and method |
CN101460522B (zh) * | 2006-04-11 | 2014-07-23 | 弗·哈夫曼-拉罗切有限公司 | 糖基化抗体 |
US20080226635A1 (en) * | 2006-12-22 | 2008-09-18 | Hans Koll | Antibodies against insulin-like growth factor I receptor and uses thereof |
CN101675339B (zh) | 2007-04-16 | 2014-04-16 | 动量制药公司 | 涉及细胞表面糖基化作用的方法 |
PL2190984T3 (pl) | 2007-09-14 | 2014-02-28 | Genovis Ab | Sposoby i zestawy do oczyszczania i wykrywania glikozylowanego IgG |
-
2010
- 2010-09-28 WO PCT/EP2010/064291 patent/WO2011039150A1/en active Application Filing
- 2010-09-28 ES ES10757221.6T patent/ES2528321T3/es active Active
- 2010-09-28 CA CA2773882A patent/CA2773882C/en not_active Expired - Fee Related
- 2010-09-28 US US13/499,887 patent/US20120196310A1/en not_active Abandoned
- 2010-09-28 EP EP10757221.6A patent/EP2483693B1/en active Active
- 2010-09-28 JP JP2012531345A patent/JP2013506404A/ja active Pending
- 2010-09-28 CN CN201080041521.1A patent/CN102511007B/zh active Active
-
2012
- 2012-09-24 HK HK12109387.8A patent/HK1168653A1/xx unknown
-
2014
- 2014-05-22 US US14/285,440 patent/US20140302544A1/en not_active Abandoned
-
2015
- 2015-01-28 JP JP2015013936A patent/JP5980353B2/ja active Active
-
2016
- 2016-06-10 US US15/179,431 patent/US10352943B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013506404A (ja) | 2013-02-28 |
US20140302544A1 (en) | 2014-10-09 |
US20170108510A1 (en) | 2017-04-20 |
US10352943B2 (en) | 2019-07-16 |
US20120196310A1 (en) | 2012-08-02 |
HK1168653A1 (en) | 2013-01-04 |
CN102511007B (zh) | 2015-04-15 |
JP5980353B2 (ja) | 2016-08-31 |
CA2773882A1 (en) | 2011-04-07 |
EP2483693A1 (en) | 2012-08-08 |
JP2015109857A (ja) | 2015-06-18 |
WO2011039150A1 (en) | 2011-04-07 |
CN102511007A (zh) | 2012-06-20 |
EP2483693B1 (en) | 2014-12-03 |
CA2773882C (en) | 2016-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2528321T3 (es) | Detección de a-fucosilación en anticuerpos | |
ECSP088081A (es) | Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente | |
ES2516266T3 (es) | Identificación de un dispositivo auto-alimentado conectado con un dispositivo médico | |
ES2572372T3 (es) | Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1 | |
TW200801202A (en) | Alpha-enolase specific antibody and method of use | |
ES2656150T3 (es) | Diagnóstico de la sepsis y del síndrome de respuesta inflamatoria sistémica | |
CL2007001329A1 (es) | Sistema y metodo para detectar una pieza danada o perdida de una maquina, donde comprende un aparato de captura de imagen de una maquina contra un fondo,el cual se mueve en relacion a la maquina en el tiempo;y un procesador para las imagenes capturadas para determinar si una o mas piezas de la maquina estan danadas o perdidas. | |
WO2014197899A3 (en) | Methods, systems and apparatus of an all-optics ultrasound sensor | |
PH12015502849A1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
SG169314A1 (en) | Method and device for detecting defects in an object | |
WO2012110898A9 (en) | System and method for multi-scanner x-ray inspection | |
BR112016009460A8 (pt) | método para detectar a presença de anticorpos neutralizantes, e, kit | |
MX2024004195A (es) | Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activacion por contacto. | |
PE20142129A1 (es) | Metodo y dispositivo para la deteccion y analisis de depositos | |
WO2014195917A3 (en) | Detector-array-based sample characterization | |
ATE474228T1 (de) | Reagenz für hämoglobinabbau | |
ES2601028T3 (es) | Método de medición inmunológica para el precursor del péptido liberador de gastrina | |
AR087654A1 (es) | METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO | |
MX2017009752A (es) | Adn huesped como biomarcador de la enfermedad de crohn. | |
EP2584526A3 (en) | Image processing device, image processing method, and image processing program | |
WO2016012864A3 (en) | Biomarkers for anderson-fabry disease | |
CL2008000062A1 (es) | Sistema portatil mediante el cual se puede determinar la calidad de un trozo de carne sin necesidad de manipularla, que permite la captura de imagenes para su posterior procesamiento; y metodo asociado. | |
DK2274623T3 (da) | Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension | |
CL2013002750A1 (es) | Dispositivo electronico para inspecionar un frondo de recipiente que contiene: una fuente de luz (12.12b,12c) dispuste en al menos un lado del recipiente, un sensor de luz (14), un procesador para desarrollar una imagen, una pantalla (22); y metodo asociado. | |
MX2024009782A (es) | Biomarcadores proteicos para enfermedades asociadas con el sistema de activacion por contacto. |